Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
124.09
-0.93 (-0.74%)
At close: Nov 17, 2025, 4:00 PM EST
124.45
+0.36 (0.29%)
After-hours: Nov 17, 2025, 7:52 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
The 22 analysts that cover Gilead Sciences stock have a consensus rating of "Buy" and an average price target of $122.09, which forecasts a -1.61% decrease in the stock price over the next year. The lowest target is $80 and the highest is $150.
Price Target: $122.09 (-1.61%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 6 | 6 |
| Buy | 13 | 12 | 12 | 12 | 10 | 11 |
| Hold | 9 | 8 | 7 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 24 | 24 | 23 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $133 → $140 | Strong Buy | Maintains | $133 → $140 | +12.82% | Nov 13, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $140 | Buy | Initiates | $140 | +12.82% | Nov 13, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $127 → $145 | Strong Buy | Reiterates | $127 → $145 | +16.85% | Nov 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $140 → $145 | Buy | Maintains | $140 → $145 | +16.85% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $145 → $150 | Buy | Maintains | $145 → $150 | +20.88% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
29.63B
from 28.75B
Increased by 3.05%
Revenue Next Year
30.61B
from 29.63B
Increased by 3.29%
EPS This Year
8.32
from 0.38
Increased by 2,088.24%
EPS Next Year
8.82
from 8.32
Increased by 6.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.2B | 32.8B | |||
| Avg | 29.6B | 30.6B | |||
| Low | 28.0B | 28.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.5% | 10.7% | |||
| Avg | 3.1% | 3.3% | |||
| Low | -2.5% | -5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.85 | 9.98 | |||
| Avg | 8.32 | 8.82 | |||
| Low | 7.89 | 6.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,229.3% | 20.0% | |||
| Avg | 2,088.2% | 6.0% | |||
| Low | 1,976.1% | -24.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.